Impact of triglyceride-glucose index on the long-term prognosis of advanced gastric cancer patients receiving immunotherapy combined with chemotherapy

doi:10.3748/wjg.v31.i5.102249

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1571)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

HTML

1038

Figures (1-5)

163

Tables (1-6)

158

Sum=1398

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=114

Feb 7, 2025 (publication date) through Apr 15, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 7, 2025; 31(5): 102249
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.102249

Table 2 Tumor responses of triglyceride glucose index < 1.79 and triglyceride glucose index ≥ 1.79, n (%)

Variables	Low TyG index (n = 164)	High TyG index (n = 136)	χ²	P value
CR
0	164 (100.00)	135 (99.26)
1	0 (0.00)	1 (0.74)
PR
0	149 (90.85)	112 (82.35)
1	15 (9.15)	24 (17.65)
SD
0	102 (62.20)	81 (59.56)
1	62 (37.80)	55 (40.44)
PD
0	77 (46.95)	80 (58.82)
1	87 (53.05)	56 (41.18)
ORR			5.49	0.020^a
0	149 (90.85)	111 (81.62)
1	15 (9.15)	25 (18.38)
DCR			4.20	0.040^a
0	87 (53.05)	56 (41.18)
1	77 (46.95)	80 (58.82)

^aP < 0.05.

TyG: Triglyceride glucose; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progression disease; ORR: Objective responds rates; DCR: Disease control rates.

Citation: Yao ZY, Ma X, Cui YZ, Liu J, Han ZX, Song J. Impact of triglyceride-glucose index on the long-term prognosis of advanced gastric cancer patients receiving immunotherapy combined with chemotherapy. World J Gastroenterol 2025; 31(5): 102249
URL: https://www.wjgnet.com/1007-9327/full/v31/i5/102249.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i5.102249